Article citationsMore>>

P. Labauge, V. Krivosic, C. Denier, E. Tounier-Lasserve and A. Gaudric, “Frequency of Retinal Cavernomas in 60 Patients with Familial Cerebral Cavernomas: A Clinical and Genetic Study,” Archives of Ophthalmology, Vol. 124, No. 6, 2006, pp. 885-886. doi:10.1001/archopht.124.6.885

has been cited by the following article:

• TITLE: Another Proliferative Diabetic Retinopathy? A Case Report of Retinal Cavernous Haemangioma Treated with Intravitreal Bevacizumab, Initially Labelled as Persistent Proliferative Diabetic Retinopathy

  AUTHORS: Myrto Tsagkataki, Ahmad Khalil, Ahmed Kamal

  KEYWORDS: Retinal Cavernous Haemangioma; Intravitreal Bevacizumab; Persistent Proliferative Diabetic Retinopathy; Vitreous Haemorrhage

  JOURNAL NAME: Open Journal of Ophthalmology, Vol.2 No.1, February 27, 2012

  ABSTRACT: We present a case of Retinal Cavernous Haemangioma treated with Intravitreal Bevacizumab, which was initially labelled as persistent proliferative diabetic retinopathy with multiple episodes of vitreous haemorrhage. These lesions can be confused with new retinal vessels in diabetics and if correctly diagnosed unnecessary photocoagulation can be avoided. Our patient received a course of three intravitreal Bevacizumab injections (1.25 mg/0.05 ml) in order to stop the leakage from the retinal cavernous haemangioma lesions and prevent another episode of vitreous haemorrhage. No intraoperative or postoperative complications were seen. Twenty-two months following treatment there was no recurrence of vitreous haemorrhage.